Marijuana companies weigh how to approach COVID-19 vaccinations for employees
Cannabis companies are seeking clarity on Covid-19 vaccinations for employees as the pandemic continues to cause logistical challenges in keeping workers safe.
Cannabis companies are seeking clarity on Covid-19 vaccinations for employees as the pandemic continues to cause logistical challenges in keeping workers safe.
Facing massive budget woes and legalization in neighboring New Jersey, politicians in New York are set to take another crack at legalizing a recreational marijuana market that could generate more than $2 billion in sales – and this time, the odds look better.
Canadian cannabis giants Canopy Growth and Aphria were among a half-dozen licensed producers cited for serious regulatory violations in Health Canada’s compliance report covering the 2018-19 fiscal year.